INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 150 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $80,000 | +17.6% | 5,418 | +5.9% | 0.00% | – |
| Q3 2019 | $68,000 | -1.4% | 5,118 | +21.5% | 0.00% | – |
| Q2 2019 | $69,000 | -42.0% | 4,213 | -39.4% | 0.00% | -100.0% |
| Q1 2019 | $119,000 | +70.0% | 6,956 | +37.2% | 0.00% | 0.0% |
| Q4 2018 | $70,000 | -50.0% | 5,071 | +4.3% | 0.00% | 0.0% |
| Q3 2018 | $140,000 | +68.7% | 4,863 | +23.6% | 0.00% | 0.0% |
| Q2 2018 | $83,000 | 0.0% | 3,935 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $83,000 | +48.2% | 3,935 | +35.7% | 0.00% | 0.0% |
| Q4 2017 | $56,000 | +107.4% | 2,900 | +163.6% | 0.00% | – |
| Q3 2017 | $27,000 | +1250.0% | 1,100 | +1000.0% | 0.00% | – |
| Q2 2017 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |